Hirsutism differential diagnosis: Difference between revisions
No edit summary |
|||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hirsutism}} | {{Hirsutism}} | ||
{{CMG}} {{AE}};{{Ochuko}} | {{CMG}} {{AE}};{{Ochuko}} {{RHN}} | ||
==Overview== | ==Overview== |
Revision as of 15:15, 20 September 2017
Hirsutism Microchapters |
Diagnosis |
---|
Treatment |
Medical Therapy |
Case Studies |
Hirsutism differential diagnosis On the Web |
Directions to Hospitals Treating Hirsutism differential diagnosis |
Risk calculators and risk factors for Hirsutism differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: ;Ogheneochuko Ajari, MB.BS, MS [2] Rasam Hajiannasab M.D.[3]
Overview
The diagnosis of hirsutism requires the exclusion of related disorders with peripheral androgen activity. Hirsutism starts shortly after puberty with a slow course and progression.
Differential Diagnosis
Diagnosis | Incidence | Onset | Common symptom |
❑ Polycystic ovary syndrome ❑ Congenital adrenal hyperplasia ❑ Ovarian and androgen secreting tumors ❑ Drug induced |
❑ 70-85% ❑ 5-15% ❑ 1-8% ❑ 0.3-0.1%
|
❑ PCOS insidious ❑ Idiopathic hirsutism Insidious
❑ HAIRAN syndrome insidious |
❑ Irregular menses, hyperandrogenism, polycystic ovary
❑ Total testosterone > 200ng and does not respond to treatment ❑ Related to medications (steroids, danazol etc) ❑ Subset of PCOS with insulin resistance and acanthosis nigricans |